- Home
- NFG vs HALO Comparison
NFG vs HALO Comparison
Compare NFG & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFG
- HALO
- Stock Information
- Founded
- NFG 1902
- HALO 1998
- Country
- NFG United States
- HALO United States
- Employees
- NFG N/A
- HALO N/A
- Industry
- NFG Oil/Gas Transmission
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NFG Utilities
- HALO Health Care
- Exchange
- NFG Nasdaq
- HALO Nasdaq
- Market Cap
- NFG 5.6B
- HALO 6.4B
- IPO Year
- NFG N/A
- HALO N/A
- Fundamental
- Price
- NFG $64.23
- HALO $49.00
- Analyst Decision
- NFG Buy
- HALO Buy
- Analyst Count
- NFG 2
- HALO 9
- Target Price
- NFG $72.50
- HALO $61.11
- AVG Volume (30 Days)
- NFG 507.6K
- HALO 2.3M
- Earning Date
- NFG 11-06-2024
- HALO 10-31-2024
- Dividend Yield
- NFG 3.21%
- HALO N/A
- EPS Growth
- NFG N/A
- HALO 61.71
- EPS
- NFG 0.84
- HALO 3.02
- Revenue
- NFG $1,944,810,000.00
- HALO $947,355,000.00
- Revenue This Year
- NFG $31.79
- HALO $23.36
- Revenue Next Year
- NFG $9.40
- HALO $15.15
- P/E Ratio
- NFG $76.46
- HALO $16.21
- Revenue Growth
- NFG N/A
- HALO 21.35
- 52 Week Low
- NFG $45.32
- HALO $33.15
- 52 Week High
- NFG $64.29
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- NFG 63.55
- HALO 43.09
- Support Level
- NFG $61.26
- HALO $42.01
- Resistance Level
- NFG $62.48
- HALO $46.20
- Average True Range (ATR)
- NFG 1.30
- HALO 2.76
- MACD
- NFG 0.33
- HALO -1.08
- Stochastic Oscillator
- NFG 98.90
- HALO 34.74
About NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. Geographically it generates revenue from the United States and majorly it generates revenue from Exploration and Production segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.